Jinhe Biotechnology(SZ:002688)2022-12-08 02:22Group 1: Company Overview - The company, Jinhe Biological, has significant sales in both domestic and international markets, with foreign market revenue accounting for 50,983.09 million in 2014, representing a substantial portion of its main business income [1] - The main products are used as feed additives to promote animal production and prevent diseases, and as purified hydrochloride for treating animal diseases [3] Group 2: Product Characteristics - The key features of feed-grade gold mycin include: (1) mature production technology with high efficacy and relatively low cost; (2) broad antibacterial spectrum effective against both Gram-negative and Gram-positive bacteria; (3) no cross-use in humans and animals, avoiding cross-resistance; (4) high safety with low-dose long-term use not causing drug residues; (5) minimal compatibility issues with other feed additives or veterinary drugs [3] Group 3: Strategic Acquisitions - The acquisition of Panfield's operating assets aims to utilize its sales channels to strengthen the company's market position and serve as a strategic development reserve for future expansion [4] Group 4: Future Development Goals - The company envisions becoming a world-leading animal health product enterprise, focusing on consolidating its advantages in biological fermentation and drug feed additives, while actively developing new products in the field of novel veterinary biological products [4]